RxDoctor Payments Data

Julie Meyer

Physician Assistant · Rapid City, SDNPI 1962434670

Payments from drug & device makers

$1,455in general payments, 2019–2025

Across 86 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$331
  • Novo Nordisk$310
  • Amgen$177
  • Pfizer$146
  • E.r. Squibb & Sons, L.L.C.$115
  • Boehringer Ingelheim$105
  • plus $272 from 7 others

What the payments were for

  • Food & beverage$1,455100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,455 in reported general payments places this provider in the 80th percentile of 548 physician assistant providers in South Dakota.

See all physician assistant providers in South Dakota

Medicare billing

Part B allowed, 2024
$342,240
Medicare patients
209
Services billed
13,758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin184$177,449
FarxigaDapagliflozin Propanediol110$86,334
OzempicSemaglutide64$83,178
EliquisApixaban73$79,097
MounjaroTirzepatide38$65,004
XareltoRivaroxaban17$25,165
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$19,395
MyrbetriqMirabegron36$16,409
Breo ElliptaFluticasone/Vilanterol30$11,906
LinzessLinaclotide15$8,912
SynthroidLevothyroxine Sodium112$7,909
Xtampza ErOxycodone Myristate12$6,779
Praluent PenAlirocumab11$6,608
TobradexTobramycin/Dexamethasone21$5,524
Novolog FlexpenInsulin Aspart14$5,242

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$105$177,449184 claims
AstraZenecaFarxiga$69$86,334110 claims
Novo NordiskOzempic$310$83,17864 claims
PfizerEliquis$146$79,09773 claims
Lilly USA, LLCMounjaro$331$65,00438 claims
Johnson & JohnsonXarelto$19$25,16517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 548 physician assistant providers in South Dakota.

Other physician assistant in Rapid City

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →